Trade Indivior PLC - INDV CFD
Add to favourite- Summary
- Historical Data
Spread | 0.1520 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.025295% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.003377% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 0.1 | ||||||||
Currency | GBP | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
Commission on trade | 0% |
Prev. Close | 9.734 |
Open | 10.0035 |
1-Year Change | -46.56% |
Day's Range | 9.5645 - 10.0035 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 9.6840 | 0.0700 | 0.73% | 9.6140 | 10.1335 | 9.2000 |
Jul 24, 2024 | 8.2965 | -0.1095 | -1.30% | 8.4060 | 8.4710 | 8.1615 |
Jul 23, 2024 | 8.3215 | 0.3395 | 4.25% | 7.9820 | 8.3215 | 7.9320 |
Jul 22, 2024 | 7.8970 | 0.0350 | 0.45% | 7.8620 | 8.1215 | 7.7425 |
Jul 19, 2024 | 7.9370 | 0.0450 | 0.57% | 7.8920 | 8.0120 | 7.8120 |
Jul 18, 2024 | 7.9170 | -0.3245 | -3.94% | 8.2415 | 8.3315 | 7.9170 |
Jul 17, 2024 | 8.2465 | 0.4595 | 5.90% | 7.7870 | 8.2565 | 7.5825 |
Jul 16, 2024 | 7.7670 | -0.0200 | -0.26% | 7.7870 | 7.9970 | 7.5175 |
Jul 15, 2024 | 7.7125 | -0.3190 | -3.97% | 8.0315 | 8.1965 | 7.5975 |
Jul 12, 2024 | 8.1815 | -0.2245 | -2.67% | 8.4060 | 8.6060 | 8.0715 |
Jul 11, 2024 | 8.3715 | 0.3645 | 4.55% | 8.0070 | 8.4560 | 7.7970 |
Jul 10, 2024 | 7.8020 | 0.0350 | 0.45% | 7.7670 | 7.8970 | 7.4125 |
Jul 9, 2024 | 7.5325 | -1.3330 | -15.04% | 8.8655 | 8.9205 | 6.5190 |
Jul 8, 2024 | 11.7610 | 0.2700 | 2.35% | 11.4910 | 11.7810 | 11.4910 |
Jul 5, 2024 | 11.6210 | 0.0800 | 0.69% | 11.5410 | 11.9705 | 11.5110 |
Jul 4, 2024 | 11.7710 | 0.2000 | 1.73% | 11.5710 | 11.8505 | 11.4910 |
Jul 3, 2024 | 11.3915 | -0.6190 | -5.15% | 12.0105 | 12.1305 | 11.3915 |
Jul 2, 2024 | 12.0705 | -0.0695 | -0.57% | 12.1400 | 12.2200 | 11.8805 |
Jul 1, 2024 | 12.2400 | -0.1400 | -1.13% | 12.3800 | 12.5595 | 11.9205 |
Jun 28, 2024 | 12.1800 | -0.5590 | -4.39% | 12.7390 | 12.7495 | 12.1800 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Indivior Company profile
About Indivior PLC
Indivior PLC is a United Kingdom-based pharmaceutical company. The Company is engaged in developing medicines to treat addiction and serious mental illnesses. It focuses to build a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as new therapies to address the needs of people suffering from alcohol, stimulant and cannabis use disorders. Its pipeline products include INDV-3000 - Selective Dopamine D3-receptor Antagonist, RBP-6000 - Buprenorphine XR injection, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet and Buprenorphine Sublingual Tablet, among others. Its portfolio of products is available in more than 40 countries.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Indivior PLC revenues increased 22% to $791M. Net income totaled $205M vs. loss of $148M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other operating income increase from $0K to $32M (income), Selling/General/Admin. Expense, decrease of 5% to $192M (expense).
Industry: | Proprietary & Advanced Pharmaceuticals |
234 Bath Road
SLOUGH
BERKSHIRE SL1 4EE
GB
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com